MAP/microtubule Affinity-Regulating Kinase 3 (MARK3) (Middle Region) Peptid
MARK3
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle MARK3 Produkte
- MARK3 (MAP/microtubule Affinity-Regulating Kinase 3 (MARK3))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-MARK3 antibody (Catalog #: ARP56343_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MARK3 (MAP/microtubule Affinity-Regulating Kinase 3 (MARK3))
- Hintergrund
-
MARK3 is involved in the specific phosphorylation of microtubule-associated proteins for tau, MAP2 and MAP4. Phosphorylates CDC25C on 'Ser-216'.
Alias Symbols: CTAK1, KP78, PAR1A, Par-1a
Protein Interaction Partner: ANKRD7,ASB13,ATP6V0C,CDC25C,CHGB,CPSF4,DYNLL1,FANCF,KSR1,NOL11,PKP2,PMPCB,PNPLA2,PRKCQ,SAAL1,SFN,TCEA2,TTR,VPS11,YWHAG,YWHAZ,ATP6V0C,CHGB,MARK2,PMPCB,PNPLA2,RASGRF1,SAAL1,SFN,TCEA2,TTR,UBC,USP21,VPS11,YWHAB,YWHAG,YWHAQ
Protein Size: 729 - Molekulargewicht
- 81 kDa
- Gen-ID
- 4140
- NCBI Accession
- NM_002376, NP_002367
-
Sie sind hier:
